TAMPA, Fla., Sept. 29, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), one of the nation's leading sources of low-cost prescription medications, announces that in an effort to push the industry to new quality standards, the Company has initiated a safety-standard campaign that focuses on giving consumers choices for affordable access to government and FDA-approved medications. Included in that safety standard is the consumer's option of choosing which country they'd like to get their medications from and at what price.
"When it comes to setting a higher safety standard, it all comes down to the sourcing of the drugs," says Rx Processing Corp. CEO Peter Fiorillo. "Not only does that make it more affordable to consumers, it also affords them 'fret-free' purchasing of their life-saving medications."
What sets RXPC apart from many other drug re-importation companies is that RXPC sells only local government approved and FDA-approved drugs at significant savings. Because of RXPC's unique affiliated storefronts, more than 130 in the United States, they compete nationally with major pharmacy chains with brand name and generic medications at a fraction of their cost. RXPC business model finds the most affordable prices on generic medicines from US suppliers, while finding branded pharmaceuticals from the Canadian suppliers, which are typically the most affordable.
Earlier this year, CEO Peter Fiorillo announced he is giving back his first year's salary of 500,000 shares of RXPC stock, to build awareness for the Dorgan-Snow Bill currently in Congress. This Congressional act legitimizes buying prescription medications from Canada allowing US citizen's access to low-cost prescription medications at 30-80% off traditional prices.
RXPC will give Fiorillo's salary away in a public drawing, designed to build awareness and support for the re-importation of prescription medications from Canada. The drawing is open to all U.S. citizens over the age of 18. In order to register for the stock giveaway, Rx Processing encourages individuals to go to the company website at www.RxProcessingCorp.com and fill out the registration form online. The registration form is also available in hard copy by RXPC directly at 800-576-7055. The deadline for the drawing is October 8, 2004.
About Rx Processing Corporation
Rx Processing Corporation is a publicly traded (Pink Sheets:RXPC) drug re-importation business that provides U.S. citizens with access to low-cost government-approved and FDA-approved prescription drugs. RXPC offers individuals the ability to order approved 'brand name and generic' prescription medications with savings of 30-80% off those sold from any pharmacy in the United States. These reduced-cost medications are available at the company's affiliate retail storefronts and through the website at www.rxprocessingcorp.com
Safe Harbor Statement -- All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.